Galacto-oligosaccharides alleviate lung inflammation by inhibiting NLRP3 inflammasome activation in vivo and in vitro

INTRODUCTION: The lack of effective anti-inflammatory therapies for pneumonia represents a challenge for identifying new alternatives. Non-digestible galacto-oligosaccharides (GOS) are attractive candidates due to their anti-inflammatory and immunomodulatory effects both locally and systemically. OB...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Yang, Gilbert, Myrthe S., Gerrits, Walter J.J., Folkerts, Gert, Braber, Saskia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263649/
https://www.ncbi.nlm.nih.gov/pubmed/35777914
http://dx.doi.org/10.1016/j.jare.2021.10.013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263649/
https://www.ncbi.nlm.nih.gov/pubmed/35777914
http://dx.doi.org/10.1016/j.jare.2021.10.013

Ejemplares similares